$VRDN news
The latest VRDN stock news: headlines, filings, AI summaries and sentiment for $VRDN, updated around the clock.
- Viridian Therapeutics, Inc.\DE - 8-K Filing
- Viridian Therapeutics Reports Q3 2026 Results Driven by Lumvoa Commercial Launch
- Viridian Therapeutics Reports Q3 Earnings Beat with $24.7 Million in Revenue
- Viridian Therapeutics, Inc.\DE - 10-Q Filing
- Viridian Therapeutics, Inc.\DE - 8-K Filing
- Viridian Therapeutics Launches FDA-Approved Drug for Thyroid Eye Disease
- Viridian Metals Identifies Copper-Rich Zones up to 4.15% at Kraken Ahead of 2026 Drill Program
- Viridian Therapeutics Prices $350M in Concurrent Public Offerings
- Viridian Therapeutics, Inc.\DE - 8-K Filing
- Viridian Therapeutics Approaches PDUFA Decision for Veligrotug in Thyroid Eye Disease
- Kopp Family Office Reduces Stake in Viridian Therapeutics by $3.5 Million
- Viridian Therapeutics (VRDN) Stock Posts Double-Digit Growth Year-on-Year
- Kopp Family Office Sells $3.5 Million Stake in Viridian Therapeutics
- Evercore ISI Lowers Price Target for Viridian Therapeutics Ahead of Earnings